AIM
BHC icon

Acrospire Investment Management’s Bausch Health BHC Stock Holding History

Acrospire Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,258
Closed -$39K – 173
2017
Q2 		$39K Sell
2,258
-1,900
-46% -$22.8K 0.04% 1082
2017
Q1 		$46K Sell
4,158
-7,500
-64% -$103K 0.04% 1024
2016
Q4 		$169K Sell
11,658
-1,542
-12% -$28.3K 0.07% 486
2016
Q3 		$324K Buy
13,200
+9,900
+300% +$256K 0.22% 13
2016
Q2 		$66K Sell
3,300
-800
-20% -$22.7K 0.05% 828
2016
Q1 		$108K Buy
+4,100
New +$303K 0.07% 276

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acrospire Investment Management's BHC Position: Q3 2017 in Review

Acrospire Investment Management sold out of Bausch Health (BHC) in Q3 2017, closing a stake of 2,258 shares — an estimated $39K sold.

Acrospire Investment Management first reported a position in BHC in Q1 2016 and held it in 6 quarters. The position peaked at $324K in Q3 2016. 289 funds tracked by Wall St. Rank hold BHC as of Q3 2017.

  • Acrospire Investment Management reported no remaining Bausch Health position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,258 Bausch Health shares in Q3 2017, an estimated $39K.
  • Acrospire Investment Management first reported a position in Bausch Health in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Bausch Health position peaked at $324K in Q3 2016.
  • 289 funds tracked by Wall St. Rank held Bausch Health as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.